Stay updated on OPUS Clinical Trial: Natalizumab in Focal Epilepsy
Sign up to get notified when there's something new on the OPUS Clinical Trial: Natalizumab in Focal Epilepsy page.

Latest updates to the OPUS Clinical Trial: Natalizumab in Focal Epilepsy page
- Check3 days agoChange DetectedThe page’s displayed software/interface revision number has been updated from v3.5.2 to v3.5.3.SummaryDifference0.0%

- Check10 days agoChange DetectedThe site revision updated from v3.5.0 to v3.5.2.SummaryDifference0.0%

- Check17 days agoNo Change Detected
- Check39 days agoChange DetectedThe page now shows an updated Revision tag: v3.5.0, replacing the previous v3.4.3.SummaryDifference0.0%

- Check46 days agoChange DetectedRevision: v3.4.3 was added and Revision: v3.4.2 was removed.SummaryDifference0.0%

- Check75 days agoChange DetectedThe page now displays Revision: v3.4.2 instead of v3.4.1; to avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.0%

- Check82 days agoChange DetectedRevision: v3.4.1 appears to replace the prior v3.4.0 without altering core study content or navigation. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.0%

Stay in the know with updates to OPUS Clinical Trial: Natalizumab in Focal Epilepsy
Enter your email address, and we'll notify you when there's something new on the OPUS Clinical Trial: Natalizumab in Focal Epilepsy page.